Data as of .
FMED vs TEKY: which is really different?
FMED and TEKY hold 0% of their weight in the same names, and FMED returned more over the year.
ETFIQ Off-Index Score: FMED scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
0% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, FMED and TEKY hold 0% of their money in the same securities at the same weight.
| Only in FMED | Only in TEKY |
|---|---|
| UCB SA 4.75% | SK hynix Inc 5.72% |
| LIFESTANCE HEALTH GROUP INC 4.29% | Alphabet Inc 5.25% |
| DANAHER CORP 3.43% | NVIDIA Corp 4.94% |
| 10X GENOMICS INC 3.12% | Taiwan Semiconductor Manufacturing Co Lt 4.00% |
| INTUITIVE SURGICAL INC 2.93% | Amazon.com Inc 3.71% |
| COGENT BIOSCIENCES INC 2.86% | Advanced Micro Devices Inc 3.69% |
| ALNYLAM PHARMACEUTICALS INC 2.80% | Broadcom Inc 3.38% |
| ARGENX SE 2.79% | Applied Materials Inc 3.19% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| FMED | TEKY | FMED | TEKY | FMED | TEKY | |
| 3 months | +21.3% | −5.5% | +19.0 pts | −7.7 pts | +23.7 pts | −3.0 pts |
| 6 months | +32.3% | +29.5% | +14.3 pts | +11.5 pts | +8.0 pts | +5.3 pts |
| 1 year | +28.3% | +16.8% | +11.7 pts | +0.2 pts | +6.5 pts | −5.0 pts |
| 3 years | +39.6% | not published | −38.8 pts | not published | −58.5 pts | not published |
| Since launch | +25.8% | +78.3% | −57.6 pts | +24.7 pts | −78.1 pts | +7.0 pts |
| FMED Fidelity Disruptive Medicine ETF Holds 68 stocks in broad innovation and megatrends, 25% of its weight in S&P 500 companies | TEKY Lazard Next Gen Technologies ETF Holds 48 stocks in broad innovation and megatrends, 52% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | Fidelity | Lazard |
| Theme | Broad innovation and megatrends | Broad innovation and megatrends |
| In the S&P 500 | 25.4% | 51.5% |
| Active share vs the S&P 500 | 97.1% | 77.6% |
| In the Nasdaq-100 | 8.7% | 43.4% |
| Holdings | 68 | 48 |
| Top ten, share of the fund | 31.5% | 39.6% |
| Expense ratio | 0.50% | 0.50% |
| Fee for the differing part | 0.51% | 0.64% |
| Total return, 1 year | +28.3% | +16.8% |
| vs the S&P 500 | +11.7 pts | +0.2 pts |
| vs the Nasdaq-100 | +6.5 pts | −5.0 pts |
| Below its high | −3.8% | −6.8% |
| Net assets | $52m | $61m |
FMED in plain words
By weight, 25% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 32% of the fund across 68 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +28.3% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 11.7 pts.
TEKY in plain words
By weight, 52% of TEKY's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 78%. The top ten holdings are 40% of the fund across 48 positions, as filed for Jun 30, 2026. Over the year to Sep 18, 2026 the fund returned +16.8% with distributions reinvested against +16.6% for the S&P 500, so a holder was about even. It sits 6.8% below its all-time high of Jun 2, 2026.
Questions people ask
- Do FMED and TEKY hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, FMED or TEKY?
- FMED has 25% of its weight in S&P 500 names and TEKY has 52%, so FMED differs more from the index.
- Which is cheaper, FMED or TEKY?
- FMED charges 0.50% a year and TEKY charges 0.50%, so FMED is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, FMED against TEKY, data as of Sep 18, 2026. https://etfiq.com/compare/themes/fmed-vs-teky Free to use with attribution; the underlying files are at Open data.